US4659717A
(en)
|
1985-08-21 |
1987-04-21 |
Eli Lilly And Company |
Dihydropyridines useful in the treatment of angina and stroke
|
CH681806A5
(es)
|
1991-03-19 |
1993-05-28 |
Ciba Geigy Ag |
|
EP0682027B1
(de)
|
1994-05-03 |
1997-10-15 |
Novartis AG |
Pyrrolopyrimidinderivate mit antiproliferativer Wirkung
|
FR2732969B1
(fr)
|
1995-04-14 |
1997-05-16 |
Adir |
Nouveaux composes pyridiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
SI9620103A
(sl)
|
1995-07-06 |
1998-10-31 |
Novartis Ag |
Pirolopirimidini in postopki za njihovo pripravo
|
US5804585A
(en)
|
1996-04-15 |
1998-09-08 |
Texas Biotechnology Corporation |
Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
|
JP4242928B2
(ja)
|
1996-08-23 |
2009-03-25 |
ノバルティス アクチエンゲゼルシャフト |
置換ピロロピリミジンおよびその製造方法
|
JP4166296B2
(ja)
|
1997-04-25 |
2008-10-15 |
塩野義製薬株式会社 |
ドーパミン受容体拮抗作用を有する化合物
|
US5939432A
(en)
|
1997-10-29 |
1999-08-17 |
Medco Research, Inc. |
Thiophenes useful for modulating the adenosine receptor
|
CN1280580A
(zh)
|
1997-11-11 |
2001-01-17 |
辉瑞产品公司 |
用作抗癌药的噻吩并嘧啶和噻吩并吡啶衍生物
|
SK18542000A3
(sk)
|
1998-06-04 |
2001-12-03 |
Abbott Laboratories |
Protizápalové zlúčeniny inhibujúce bunkovú adhéziu
|
JP3270834B2
(ja)
|
1999-01-27 |
2002-04-02 |
ファイザー・プロダクツ・インク |
抗がん剤として有用なヘテロ芳香族二環式誘導体
|
EP1181296A1
(en)
|
1999-06-03 |
2002-02-27 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
CN1615873A
(zh)
|
1999-12-24 |
2005-05-18 |
阿文蒂斯药物有限公司 |
氮杂吲哚类化合物
|
CZ20023199A3
(cs)
|
2000-02-25 |
2003-05-14 |
F. Hoffmann-La Roche Ag |
Modulátory receptoru adenosinu
|
WO2002051849A1
(fr)
|
2000-12-26 |
2002-07-04 |
Daiichi Pharmaceutical Co., Ltd. |
Inhibiteurs cdk4
|
WO2003000194A2
(en)
|
2001-06-21 |
2003-01-03 |
Pfizer Inc. |
Thienopyridine and thienopyrimidine anticancer agents
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
WO2003000690A1
(en)
|
2001-06-25 |
2003-01-03 |
Aventis Pharmaceuticals Inc. |
Synthesis of heterocyclic compounds employing microwave technology
|
GB0119249D0
(en)
|
2001-08-07 |
2001-10-03 |
Novartis Ag |
Organic compounds
|
EP1442028A4
(en)
|
2001-11-06 |
2009-11-04 |
Bristol Myers Squibb Co |
SUBSTITUTED ACID DERIVATIVES, WHICH APPRECIATE AS ANTIDIBILICS AND AGENTS AGAINST OBESITAS, AND METHODS
|
US7498349B2
(en)
|
2002-08-02 |
2009-03-03 |
Genesoft Pharmaceuticals, Inc. |
Biaryl compounds having anti-infective activity
|
US20050288299A1
(en)
|
2002-10-09 |
2005-12-29 |
Mavunkel Babu J |
Azaindole derivatives as inhibitors of p38 kinase
|
WO2004032874A2
(en)
|
2002-10-09 |
2004-04-22 |
Scios Inc. |
AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE
|
US7384965B2
(en)
|
2003-01-06 |
2008-06-10 |
Eli Lilly And Company |
Fused heterocyclic derivatives as PPAR modulators
|
JP2006520796A
(ja)
|
2003-03-17 |
2006-09-14 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼインヒビター
|
WO2004093812A2
(en)
|
2003-04-22 |
2004-11-04 |
Irm Llc |
Compounds that induce neuronal differentiation in embryonic stem cells
|
SE0301372D0
(sv)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Novel compounds
|
DE10337942A1
(de)
|
2003-08-18 |
2005-03-17 |
Merck Patent Gmbh |
Aminobenzimidazolderivate
|
JP2005194198A
(ja)
|
2003-12-26 |
2005-07-21 |
Takeda Chem Ind Ltd |
チエノピリジン化合物
|
US20050165029A1
(en)
|
2004-01-13 |
2005-07-28 |
Ambit Biosciences Corporation |
Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
|
WO2005080377A1
(ja)
|
2004-02-20 |
2005-09-01 |
Kirin Beer Kabushiki Kaisha |
TGFβ阻害活性を有する化合物およびそれを含んでなる医薬組成物
|
WO2005081960A2
(en)
|
2004-02-25 |
2005-09-09 |
Wyeth |
Inhibitors of protein tyrosine phosphatase 1b
|
GB0412467D0
(en)
|
2004-06-04 |
2004-07-07 |
Astrazeneca Ab |
Chemical compounds
|
WO2005121125A1
(en)
|
2004-06-09 |
2005-12-22 |
Pfizer Inc. |
Ether-linked heteroaryl compounds
|
US20060058339A1
(en)
|
2004-06-17 |
2006-03-16 |
Ibrahim Prabha N |
Compounds modulating c-kit activity and uses therefor
|
US20050288290A1
(en)
|
2004-06-28 |
2005-12-29 |
Borzilleri Robert M |
Fused heterocyclic kinase inhibitors
|
WO2006014325A2
(en)
|
2004-07-02 |
2006-02-09 |
Exelixis, Inc. |
C-met modulators and method of use
|
FR2873694B1
(fr)
|
2004-07-27 |
2006-12-08 |
Merck Sante Soc Par Actions Si |
Nouveaux aza-indoles inhibiteurs de la mtp et apob
|
JP5096142B2
(ja)
|
2004-07-30 |
2012-12-12 |
メチルジーン インコーポレイテッド |
Vegfレセプターおよびhgfレセプターシグナル伝達の阻害剤
|
US7465726B2
(en)
|
2004-08-02 |
2008-12-16 |
Osi Pharmaceuticals, Inc. |
Substituted pyrrolo[2.3-B]pyridines
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
EP1802305A2
(en)
|
2004-10-19 |
2007-07-04 |
The Regents of The University of California |
Compositions and methods for disruption of brca2-rad51 interaction
|
JP2008517896A
(ja)
|
2004-10-21 |
2008-05-29 |
ファイザー・インク |
C型肝炎ウイルスプロテアーゼの阻害剤並びにそれを用いた組成物及び治療
|
CN101072759B
(zh)
|
2004-11-18 |
2013-06-19 |
Synta医药公司 |
调节hsp90活性的***化合物
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
US20060183758A1
(en)
|
2005-02-17 |
2006-08-17 |
Cb Research And Development, Inc. |
Method for synthesis of AZA-annelated pyrroles, thiophenes, and furans
|
WO2006092430A1
(de)
|
2005-03-03 |
2006-09-08 |
Universität des Saarlandes |
Selektive hemmstoffe humaner corticoidsynthasen
|
US7557103B2
(en)
|
2005-04-05 |
2009-07-07 |
Eli Lilly And Company |
Imidazopyridazine compounds
|
ATE524467T1
(de)
|
2005-04-25 |
2011-09-15 |
Merck Patent Gmbh |
Neuartige aza-heterozyklen als kinase-inhibitoren
|
WO2006124874A2
(en)
|
2005-05-12 |
2006-11-23 |
Kalypsys, Inc. |
Inhibitors of b-raf kinase
|
ES2473341T3
(es)
|
2005-05-20 |
2014-07-04 |
Methylgene Inc |
Inhibidores de la se�alizaci�n del receptor del VEGF y del receptor del HGF
|
ES2623221T3
(es)
|
2005-05-20 |
2017-07-10 |
Methylgene Inc |
Inhibidores de la señalización del receptor de VEGF y del receptor de HGF
|
KR100546041B1
(ko)
|
2005-05-31 |
2006-01-26 |
가야에이엠에이 주식회사 |
로터리 킬른형 노를 사용한 탄화티타늄 분말의 제조방법
|
US20060281768A1
(en)
|
2005-06-10 |
2006-12-14 |
Gaul Michael D |
Thienopyrimidine and thienopyridine kinase modulators
|
US20060281769A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators
|
WO2007028145A2
(en)
|
2005-09-02 |
2007-03-08 |
Dara Biosciences, Inc. |
Agents and methods for reducing protein tyrosine phosphatase 1b activity in the central nervous system
|
WO2007035428A1
(en)
|
2005-09-15 |
2007-03-29 |
Bristol-Myers Squibb Company |
Met kinase inhibitors
|
AR056200A1
(es)
|
2005-09-27 |
2007-09-26 |
Wyeth Corp |
Tieno [2,3-b]piridin-5-carbonitrilos como inhibidores de proteina quinasa
|
WO2007064861A2
(en)
|
2005-12-02 |
2007-06-07 |
Brandeis University |
Asymmetric friedel-crafts alkylations catalyzed by byfunctional cinchona alkaloids
|
EP1963320A1
(en)
|
2005-12-07 |
2008-09-03 |
OSI Pharmaceuticals, Inc. |
Pyrrolopyridine kinase inhibiting compounds
|
AR060061A1
(es)
|
2006-03-22 |
2008-05-21 |
Methylgene Inc |
Inhibidores de la actividad de la proteina tirosina quinasa
|
WO2007120726A2
(en)
|
2006-04-11 |
2007-10-25 |
The Regents Of The University Of California |
Compositions and methods related to rad51 inactivation in the treatment of neoplastic diseases, and especially cml
|
EP2040546A4
(en)
|
2006-06-22 |
2009-12-23 |
Merck & Co Inc |
TYROSINE KINASE INHIBITORS
|
PE20121506A1
(es)
|
2006-07-14 |
2012-11-26 |
Amgen Inc |
Compuestos triazolopiridinas como inhibidores de c-met
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
US20080021217A1
(en)
|
2006-07-20 |
2008-01-24 |
Allen Borchardt |
Heterocyclic inhibitors of rho kinase
|
ZA200900670B
(en)
|
2006-08-08 |
2010-04-28 |
Millennium Pharm Inc |
Heteroaryl compounds useful as inhititors of E1 activating enzymes
|
AU2007284537B2
(en)
|
2006-08-17 |
2012-04-12 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate HSP90 activity
|
WO2008049855A2
(en)
|
2006-10-27 |
2008-05-02 |
Glaxo Group Limited |
7-azaindole derivatives as c-met kinase inhibitors
|
JP2010510177A
(ja)
|
2006-11-17 |
2010-04-02 |
クイーンズ ユニバーシティ アット キングストン |
タンパク質フォールディング障害を治療するための化合物および方法
|
US8076350B2
(en)
|
2006-12-22 |
2011-12-13 |
Abbott Laboratories |
Spirocyclic azaadamantane derivatives and methods of use
|
WO2008086053A1
(en)
|
2007-01-03 |
2008-07-17 |
Virobay, Inc. |
Hcv inhibitors
|
US20080194557A1
(en)
|
2007-01-18 |
2008-08-14 |
Joseph Barbosa |
Methods and compositions for the treatment of pain, inflammation and cancer
|
WO2008089310A2
(en)
|
2007-01-18 |
2008-07-24 |
Lexicon Pharmaceuticals, Inc. |
Delta 5 desaturase inhibitors for the treatment of obesity
|
EP2137158A4
(en)
|
2007-02-28 |
2012-04-18 |
Methylgene Inc |
LOW-MOLECULAR INHIBITORS OF PROTEINARGININE METHYLTRANSFERASES (PRMTS)
|
EP2134682B1
(en)
|
2007-04-13 |
2011-12-14 |
Sanofi |
A transition metal catalyzed synthesis of n-aminoindoles
|
WO2008135232A1
(en)
|
2007-05-02 |
2008-11-13 |
Riccardo Cortese |
Use and compositions of purine derivatives for the treatment of proliferative disorders
|
JP2008308448A
(ja)
|
2007-06-15 |
2008-12-25 |
Sankyo Agro Kk |
(3−硫黄原子置換フェニル)へテロアリール誘導体
|
DE102007027800A1
(de)
|
2007-06-16 |
2008-12-18 |
Bayer Healthcare Ag |
Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
|
CA2694218A1
(en)
|
2007-07-31 |
2009-02-05 |
Schering Corporation |
Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment
|
WO2009027732A1
(en)
|
2007-08-24 |
2009-03-05 |
Astrazeneca Ab |
5-6-bicyclic heteroaromatic compounds with antibacterial activity
|
DE102007048716A1
(de)
|
2007-10-11 |
2009-04-23 |
Merck Patent Gmbh |
Imidazo[1,2-a]pyrimidinderivate
|
EP2328586A2
(en)
|
2008-05-20 |
2011-06-08 |
Cephalon, Inc. |
Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands
|
CA2728559A1
(en)
|
2008-07-03 |
2010-01-07 |
Exelixis Inc. |
Cdk modulators
|
UY31982A
(es)
|
2008-07-16 |
2010-02-26 |
Boehringer Ingelheim Int |
Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
|
UY31984A
(es)
|
2008-07-16 |
2010-02-26 |
Boehringer Ingelheim Int |
DERIVADOS DE 1-(3,4-difluorobencil)-6-oxo-1,6-dihidropirimidin-5-carboxamidas N-sustituidas y de 2-(3,4-difluorobencil)-3-oxo-2,3-dihidro-1H-pirazol-4-carboxamidas N-sustituidas.
|
US20110218211A1
(en)
|
2008-08-16 |
2011-09-08 |
Genentech, Inc. |
Azaindole inhibitors of iap
|
WO2010021686A1
(en)
|
2008-08-18 |
2010-02-25 |
Promega Corporation |
Luminogenic compounds and methods to detect cytochrome p450 3a enzymes
|
WO2010020000A1
(en)
|
2008-08-19 |
2010-02-25 |
The University Of Sydney |
Novel compounds and their uses in diagnosis
|
AR073739A1
(es)
|
2008-09-10 |
2010-12-01 |
Kalypsys Inc |
Aminopirimidinas como inhibidores de los receptores de histamina
|
CN102232071B
(zh)
|
2008-09-26 |
2016-03-23 |
财团法人卫生研究院 |
作为蛋白激酶抑制剂的稠合多环化合物
|
US8293897B2
(en)
|
2008-10-14 |
2012-10-23 |
Ning Xi |
Compounds comprising a spiro-ring and methods of use
|
KR100961410B1
(ko)
|
2008-10-14 |
2010-06-09 |
(주)네오팜 |
단백질 키나제 억제제로서 헤테로사이클릭 화합물
|
WO2010054285A2
(en)
|
2008-11-10 |
2010-05-14 |
National Health Research Institutes |
Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
|
GB2465405A
(en)
|
2008-11-10 |
2010-05-19 |
Univ Basel |
Triazine, pyrimidine and pyridine analogues and their use in therapy
|
TW201028399A
(en)
|
2008-11-27 |
2010-08-01 |
Shionogi & Co |
Pyrimidine derivative and pyridine derivative both having pi3k inhibitory activity
|
AU2009330131B2
(en)
|
2008-12-23 |
2015-09-03 |
Aquilus Pharmaceuticals, Inc |
Compounds and methods for the treatment of pain and other diseases
|
WO2010104306A2
(ko)
|
2009-03-07 |
2010-09-16 |
주식회사 메디젠텍 |
세포핵에서 세포질로의 gsk3의 이동을 억제하는 화합물을 함유하는 세포핵에서 세포질로의 gsk3 이동에 의해 발생되는 질환의 치료 또는 예방용 약학적 조성물
|
AR075858A1
(es)
|
2009-03-18 |
2011-05-04 |
Schering Corp |
Compuestos biciclicos como inhibidores de diacilglicerol aciltransferasa
|
EP2411057B1
(en)
|
2009-03-23 |
2020-05-06 |
Eli Lilly and Company |
Imaging agents for detecting neurological disorders
|
EP2417133A1
(en)
|
2009-04-06 |
2012-02-15 |
PTC Therapeutics, Inc. |
Compounds and methods for antiviral treatment
|
KR101070223B1
(ko)
|
2009-05-14 |
2011-10-06 |
덕산하이메탈(주) |
아릴아미노 구조를 포함하는 화합물 및 이를 이용한 유기전기소자, 그 단말
|
US20120172369A1
(en)
|
2009-09-14 |
2012-07-05 |
Ting Pauline C |
Inhibitors of diacylglycerol acyltransferase
|
US9095596B2
(en)
|
2009-10-15 |
2015-08-04 |
Southern Research Institute |
Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such
|
EP2490530A4
(en)
|
2009-10-22 |
2014-01-22 |
Univ Washington |
COMPOUNDS AND METHOD FOR THE TREATMENT OF BACTERIAL INFECTIONS
|
US9062076B2
(en)
|
2009-10-22 |
2015-06-23 |
Fibrotech Therapeutics Pty Ltd |
Fused ring analogues of anti-fibrotic agents
|
GB0919380D0
(en)
|
2009-11-04 |
2009-12-23 |
Almac Discovery Ltd |
Pharmaceutical compouds
|
EA022458B1
(ru)
|
2009-12-28 |
2016-01-29 |
Дженерал Инкорпорейтед Ассошиэйшн Фарма Вэлли Проджект Саппортинг Организейшн |
1,3,4-оксадиазол-2-карбоксамидное соединение
|
MX2012009377A
(es)
|
2010-02-11 |
2012-09-12 |
Univ Vanderbilt |
Benzotiazoles y azabenzotiazoles como potenciadores alostericos mglur4, composiciones y metodos para tratar la disfuncion neurologica.
|
UY33304A
(es)
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
US20110312996A1
(en)
|
2010-05-17 |
2011-12-22 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
WO2011149827A1
(en)
|
2010-05-24 |
2011-12-01 |
Glaxosmithkline Llc |
Compounds and methods
|
ES2526124T3
(es)
|
2010-06-16 |
2015-01-07 |
Cymabay Therapeutics, Inc. |
Agonistas del receptor GPR120 y sus usos
|
FR2963268B1
(fr)
|
2010-07-27 |
2015-03-13 |
Areva Nc |
Dispositif d'avivage de meule de travail et son utilisation dans une rectifieuse sans centre de pastilles de combustible nucleaire
|
DE102010033548A1
(de)
|
2010-08-05 |
2012-02-09 |
Merck Patent Gmbh |
Materialien für elektronische Vorrichtungen
|
WO2012024670A2
(en)
|
2010-08-20 |
2012-02-23 |
University Of Washington Through Its Center For Commercialization |
Composition and methods for treating glioblastoma
|
US20130317045A1
(en)
*
|
2010-09-01 |
2013-11-28 |
Ambit Biosciences Corporation |
Thienopyridine and thienopyrimidine compounds and methods of use thereof
|
EP2426202A1
(en)
|
2010-09-03 |
2012-03-07 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Kinases as targets for anti-diabetic therapy
|
TW201219401A
(en)
|
2010-09-14 |
2012-05-16 |
Lexicon Pharmaceuticals Inc |
Bicyclic inhibitors of Notum Pectinacetylesterase and methods of their use
|
CN102399233B
(zh)
|
2010-09-15 |
2014-08-13 |
山东轩竹医药科技有限公司 |
PI3K和mTOR双重抑制剂类化合物
|
US10005750B2
(en)
|
2010-10-06 |
2018-06-26 |
J-Pharma Co., Ltd. |
Developing potent urate transporter inhibitors: compounds designed for their uricosuric action
|
CN103221048A
(zh)
|
2010-11-18 |
2013-07-24 |
卡斯纳莱拉创新药物私人有限公司 |
取代的4-(硒吩-2(或3)-基氨基)嘧啶化合物及其使用方法
|
JP5720253B2
(ja)
|
2011-01-06 |
2015-05-20 |
コニカミノルタ株式会社 |
有機エレクトロニクス素子、それを具備した表示装置及び照明装置
|
US8759386B2
(en)
|
2011-01-24 |
2014-06-24 |
Boehringer Ingelheim International Gmbh |
Pyrazole compounds as CRTH2 antagonists
|
ES2734878T3
(es)
|
2011-02-01 |
2019-12-12 |
Univ Illinois |
Derivados de N-hidroxibenzamida como inhibidores de HDAC y métodos terapéuticos que utilizan los mismos
|
BR112013020329A2
(pt)
|
2011-02-09 |
2016-08-02 |
Hoffmann La Roche |
compostos heterocíclicos como inibidores da pi3-quinase
|
WO2012130829A1
(en)
|
2011-03-29 |
2012-10-04 |
Biolog Life Science Institute Forschungslabor Und Biochemica-Vertrieb Gmbh |
New boranophosphate analogues of cyclic nucleotides
|
KR20120119932A
(ko)
|
2011-04-21 |
2012-11-01 |
(주)네오팜 |
Pi3 키나제 억제제로서 헤테로고리 화합물
|
WO2012154888A1
(en)
|
2011-05-09 |
2012-11-15 |
Proteostasis Therapeutics, Inc. |
Compounds for treating protein folding disorders
|
EP2710018B8
(en)
|
2011-05-19 |
2022-02-23 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Macrocyclic compounds as protein kinase inhibitors
|
DE102011111400A1
(de)
|
2011-08-23 |
2013-02-28 |
Merck Patent Gmbh |
Bicyclische heteroaromatische Verbindungen
|
WO2013033981A1
(zh)
|
2011-09-06 |
2013-03-14 |
江苏先声药物研究有限公司 |
一类2,7-萘啶衍生物及其制备方法和应用
|
US20130096136A1
(en)
|
2011-09-30 |
2013-04-18 |
Methylgene Inc. |
Inhibitors of Protein Tyrosine Kinase Activity
|
JP5741373B2
(ja)
|
2011-10-25 |
2015-07-01 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子材料、有機エレクトロルミネッセンス素子、表示装置、並びに照明装置
|
AR090037A1
(es)
|
2011-11-15 |
2014-10-15 |
Xention Ltd |
Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
|
WO2013078254A1
(en)
|
2011-11-22 |
2013-05-30 |
Array Biopharma Inc. |
Bicyclic heteroaryl derivatives as kinase inhibitors
|
GB201120993D0
(en)
|
2011-12-06 |
2012-01-18 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
WO2013085339A2
(ko)
|
2011-12-07 |
2013-06-13 |
주식회사 두산 |
유기 발광 화합물 및 이를 이용한 유기 전계 발광 소자
|
TW201728592A
(zh)
|
2012-01-10 |
2017-08-16 |
林伯士艾瑞斯公司 |
Irak抑制劑及其用途
|
KR20150003767A
(ko)
|
2012-04-26 |
2015-01-09 |
브리스톨-마이어스 스큅 컴퍼니 |
혈소판 응집을 치료하기 위한 프로테아제 활성화 수용체 4 (par4) 억제제로서의 이미다조티아디아졸 유도체
|
WO2013165898A2
(en)
|
2012-05-01 |
2013-11-07 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for inhibiting resolvases
|
KR101537436B1
(ko)
|
2012-08-17 |
2015-07-17 |
주식회사 두산 |
신규 화합물 및 이를 포함하는 유기 전계 발광 소자
|
CN103626783B
(zh)
|
2012-08-22 |
2016-06-08 |
中国科学院上海药物研究所 |
双环稠杂环化合物及其用途和药物组合物
|
RU2769516C2
(ru)
|
2012-10-02 |
2022-04-01 |
Кэлифорниа Инститьют Оф Текнолоджи |
Восстановительное расщепление ароматических связей c-s активированными силанами
|
CN104822690B
(zh)
|
2012-10-02 |
2017-08-25 |
加州理工学院 |
芳族化合物的无过渡金属的甲硅烷基化
|
US9556135B2
(en)
|
2012-10-12 |
2017-01-31 |
Amgen, Inc. |
Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
|
KR101547623B1
(ko)
|
2012-10-24 |
2015-08-26 |
주식회사 두산 |
유기 전계 발광 소자
|
CN103833753B
(zh)
|
2012-11-22 |
2017-02-01 |
广东东阳光药业有限公司 |
炔基化合物及其使用方法和用途
|
US20140148492A1
(en)
|
2012-11-23 |
2014-05-29 |
Boehringer Ingelheim International Gmbh |
Bicyclosubstituted pyrazole compounds for treating hair loss
|
WO2014089280A1
(en)
|
2012-12-07 |
2014-06-12 |
Calitor Sciences, Llc |
Alkynyl compounds and methods of use
|
CN103012428A
(zh)
|
2013-01-08 |
2013-04-03 |
中国药科大学 |
4-(五元杂环并嘧啶/吡啶取代)氨基-1H-3-吡唑甲酰胺类CDK/Aurora双重抑制剂及其用途
|
US9725430B2
(en)
|
2013-01-16 |
2017-08-08 |
Children's Hospital Medical Center |
Use of small molecule inhibitors targeting EYA tyrosine phosphatase
|
US9505781B2
(en)
|
2013-03-13 |
2016-11-29 |
The Regents Of The University Of Michigan |
Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof
|
US9499534B2
(en)
*
|
2013-04-26 |
2016-11-22 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
|
CN104119331B
(zh)
|
2013-04-26 |
2018-02-06 |
广东东阳光药业有限公司 |
烯基化合物及其使用方法和用途
|
US9351494B2
(en)
|
2013-05-03 |
2016-05-31 |
Inscent, Inc. |
Honeybee repellents and uses thereof
|
WO2014179785A1
(en)
|
2013-05-03 |
2014-11-06 |
Inscent, Inc. |
Improved honeybee repellents and uses thereof
|
WO2014193647A2
(en)
|
2013-05-26 |
2014-12-04 |
Calitor Sciences, Llc |
Alkenyl compounds and methods of use
|
WO2014194242A2
(en)
|
2013-05-31 |
2014-12-04 |
Nimbus Iris, Inc. |
Flt3 inhibitors and uses thereof
|
WO2014194245A2
(en)
|
2013-05-31 |
2014-12-04 |
Nimbus Iris, Inc. |
Cdk8 inhibitors and uses thereof
|
EP2818472A1
(en)
|
2013-06-27 |
2014-12-31 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators
|
WO2015042078A2
(en)
|
2013-09-22 |
2015-03-26 |
Calitor Sciences, Llc |
Substituted aminopyrimidine compounds and methods of use
|
KR20160076519A
(ko)
|
2013-10-10 |
2016-06-30 |
아락세스 파마 엘엘씨 |
Kras g12c 억제제
|
SG11201602982YA
(en)
|
2013-10-17 |
2016-05-30 |
Abbvie Deutschland |
Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
EP3444251B1
(en)
|
2013-12-11 |
2023-06-07 |
Biogen MA Inc. |
Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology
|
JP2017514866A
(ja)
|
2014-05-06 |
2017-06-08 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
Braf阻害剤を使用する創傷治癒
|
KR101713530B1
(ko)
|
2014-05-16 |
2017-03-08 |
(주)피엔에이치테크 |
유기발광 화합물 및 이를 포함하는 유기전계발광소자
|
KR101998435B1
(ko)
|
2014-06-09 |
2019-07-09 |
주식회사 두산 |
유기 전계 발광 소자
|
WO2016022446A1
(en)
|
2014-08-08 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
[5,6]-fused bicyclic antidiabetic compounds
|
HRP20211778T1
(hr)
|
2014-08-29 |
2022-03-18 |
Chdi Foundation, Inc. |
Kontrastna sredstva za slikovnu dijagnostiku huntingtin proteina
|
US10246464B2
(en)
|
2014-09-09 |
2019-04-02 |
The Regents Of The University Of Michigan |
Thienopyrimidine and thienopyridine compounds and methods of use thereof
|
KR101708097B1
(ko)
|
2014-10-22 |
2017-02-17 |
주식회사 두산 |
유기 전계 발광 소자
|
PT3209655T
(pt)
|
2014-10-24 |
2020-11-13 |
Landos Biopharma Inc |
Produtos terapêuticos à base da lancl2
|
CA2964282C
(en)
*
|
2014-10-27 |
2023-03-07 |
University Health Network |
Ripk2 inhibitors and method of treating cancer with same
|
CN105712998B
(zh)
|
2014-12-05 |
2019-12-13 |
上海润诺生物科技有限公司 |
氮杂吲哚类衍生物、其制备方法及其在医药上的应用
|
ES2746839T3
(es)
|
2014-12-18 |
2020-03-09 |
Pfizer |
Derivados de pirimidina y triazina y su uso como inhibidores de AXL
|
JP6038111B2
(ja)
|
2014-12-27 |
2016-12-07 |
ヤマサ醤油株式会社 |
多置換7−デアザプリン誘導体合成のための2,6−ジクロロ−8−ヨード−7−デアザプリン
|
WO2016115360A1
(en)
|
2015-01-14 |
2016-07-21 |
Coferon, Inc. |
C-myc ligands capable of dimerizing in an aqueous solution, and methods of using same
|
BR112017019371A2
(pt)
|
2015-03-12 |
2018-07-03 |
Syngenta Participations Ag |
derivados tetracíclicos ativos em termos pesticidas com substituintes contendo enxofre
|
JP6070756B2
(ja)
|
2015-04-15 |
2017-02-01 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子材料、有機エレクトロルミネッセンス素子、有機エレクトロルミネッセンス素子の製造方法、表示装置、並びに照明装置
|
EP3307798B1
(en)
|
2015-06-12 |
2020-08-05 |
Transitions Optical, Inc. |
Alignment compounds
|
EP3322711B1
(en)
|
2015-06-25 |
2021-03-10 |
University Health Network |
Hpk1 inhibitors and methods of using same
|
JP2018524337A
(ja)
|
2015-07-01 |
2018-08-30 |
シンジェンタ パーティシペーションズ アーゲー |
硫黄含有置換基を有する有害生物防除に活性な四環式誘導体
|
EP3319940B1
(en)
|
2015-07-10 |
2019-05-29 |
Technische Universität Braunschweig |
New indole compounds having antiprotozoal activity and its use as well as methods for producing the same
|
DE102015008860A1
(de)
|
2015-07-14 |
2017-01-19 |
Voxeljet Ag |
Vorrichtung zum Justieren eines Druckkopfes
|
US20170010630A1
(en)
|
2015-07-22 |
2017-01-12 |
Boe Technology Group Co., Ltd. |
Touch Display Screen, Method for Preparing Touch Display Screen and Attaching Adhesive Jig
|
GB201521767D0
(en)
|
2015-12-10 |
2016-01-27 |
Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R&D |
Therapeutic agents
|
MX2018007703A
(es)
|
2015-12-22 |
2018-11-09 |
Vitae Pharmaceuticals Inc |
Inhibidores de la interaccion de menina-linaje leucemico mixto.
|
WO2017133664A1
(en)
|
2016-02-05 |
2017-08-10 |
Savira Pharmaceuticals Gmbh |
Bicyclic pyridine and pyrimidine derivatives and their use in the treatment, amelioration or prevention of influenza
|
ES2883450T3
(es)
|
2016-02-17 |
2021-12-07 |
Global Blood Therapeutics Inc |
Inhibidores de histona metiltransferasa
|
WO2017144341A1
(de)
|
2016-02-23 |
2017-08-31 |
Bayer Cropscience Aktiengesellschaft |
Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
|
CN107151240A
(zh)
|
2016-03-04 |
2017-09-12 |
中国科学院上海药物研究所 |
一类多取代喹诺酮类化合物及其制备方法和用途
|
KR102646115B1
(ko)
|
2016-03-11 |
2024-03-12 |
에이씨 이뮨 에스에이 |
진단 및 치료를 위한 바이사이클릭 화합물
|
US11332729B2
(en)
|
2016-08-24 |
2022-05-17 |
California Institute Of Technology |
Engineered synthase for production of tryptophan derivatives and intransigent substrates
|
UA123287C2
(uk)
*
|
2016-09-15 |
2021-03-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
Гетероарилкарбоксамідні сполуки як інгібітори ripk2
|
US10138222B2
(en)
*
|
2016-09-15 |
2018-11-27 |
Boehringer Ingelheim International Gmbh |
Substituted benzamides as RIPK2 inhibitors
|
WO2018213219A1
(en)
|
2017-05-15 |
2018-11-22 |
University Of Houston System |
Pyrido[2,3-d]pyrimidin-7ones and related compounds as inhibitors of protein kinases
|
US20190002460A1
(en)
|
2017-06-28 |
2019-01-03 |
The Regents Of The University Of Michigan |
Small molecule inhibitors of egfr and pi3k
|
CN113874015A
(zh)
|
2018-12-21 |
2021-12-31 |
细胞基因公司 |
Ripk2的噻吩并吡啶抑制剂
|